Autres langues ABL Diagnostics

Actions

ABLD

FR001400AHX6

Temps réel Euronext Paris Autres places de cotation 11:30:22 20/05/2024			Varia. 5j.	Varia. 1 janv.
3,04 ^EUR	0,00 %		-0,65 %	-68,66 %

2023	ABL Diagnostics Société anonyme publie ses résultats pour le semestre clos le 30 juin 2023	CI
2023	ABL Diagnostics Société anonyme publie ses résultats pour l'exercice clos le 31 décembre 2022	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

ABL Diagnostics and Laborama officially appointed to offer NGS genotyping solutions to the National Laboratory for Public Health (NLPH) in Lithuania.	13/05
AdvancedDx Biological Laboratories USA Inc. and Medline Industries, LP to distribute Next Generation Sequencing (NGS) Prep Kits in the U.S.	17/04
AdvancedDx Biological Laboratories USA Inc. expands its logistics and storage capacity for supporting and managing third-parties' clinical trials in the USA	16/04
ABL Diagnostics appoints PALEX to offer NGS genotyping applications & Sanger to microbiology laboratories in Spain.	18/03
Block trading of ABL Diagnostics ordinary shares (ABLD, Euronext, compartment B)	04/03
Carrying Out Research About HIV Whole Genome using a Kit Now Available in the USA	28/02
ABL Diagnostics and AB ANALITICA join forces to offer microbiology genotyping solutions in Italy.	28/02
AdvancedDx Biological Laboratories USA Inc. announces its new temperature-controlled warehouse in the USA	20/02
ABL Diagnostics announces the release of its DeepChek®-HPV Assay, to be used for Human Papillomavirus screening, genotyping, and discrimination through sequencing.	18/01
ABL Diagnostics Société anonyme Reports Earnings Results for the Half Year Ended June 30, 2023	21/12
ABL DIAGNOSTICS INTRODUCING CRISPRCHEK - A NEW LINE OF ASSAYS USING THE CRISPR TECHNOLOGY	18/12
ABL Diagnostics releases new applications for respiratory viruses including Influenza, RSV and SARS-CoV-2	06/12
ABL DIAGNOSTICS EXPANDS ITS HIV GENOTYPING ASSAYS OFFERING	30/11
ABL Diagnostics expands its commercial network and collaborations to offer unique Sanger & NGS based microbiology genotyping assays and software worldwide.	24/11
ABL Diagnostics Société anonyme Reports Earnings Results for the Full Year Ended December 31, 2022	01/08/23
Roche, ABL Diagnostics Sign Distribution Partnership in South Africa	27/03/23
Roche Diagnostics (Pty) Ltd and ABL Diagnostics enter into an Exclusive Distribution Agreement in South Africa	27/03/23
ABL Diagnostics Société anonyme Reports Earnings Results for the Half Year Ended June 30, 2022	02/09/22
Advanced Biological Laboratories S.A. completed the acquisition of a 96.7% stake in ABL Diagnostics Société anonyme (ENXTPA : ABLD) from STE Parisienne De Construction Et De Location and seven natural persons.	31/08/22
ABL Diagnostics : New Distribution Partnership in Ethiopia & Bolivia	09/06/22

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues ABL Diagnostics

Actions

ABLD

FR001400AHX6

Autres langues

Filtres